.png "Jason Liebowitz, MD photo")
Jason Liebowitz, MD
Columbia University Medical Center
Englewood, New Jersey, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Reema Syed, MD, MBBS
Washington University School of Medicine in Saint Louis
olivette, Missouri, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Reema Syed, MD, MBBS
Washington University School of Medicine in Saint Louis
olivette, Missouri, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
David Fernandez, MD, PhD
Hospital for Special Surgery
New York, New York, United States
Disclosure information not submitted.
Somatic mutations have long been a recognized cause of cancer, but what about nonmalignant conditions? With stories like VEXAS, Erdheim-Chester disease, autoimmune lymphoproliferative syndrome (ALPS), and others in recent years, the importance of understanding somatic mutations as the cause of "benign" diseases has grown substantially. This session will provide a masterclass on the subject from two world renowned speakers. The first is Dr. Neal Young, chief of the Hematology Branch of the National Institutes of Health (NIH), and Director of the Center for Human Immunology at the NIH. Dr. Young is an expert on somatic mutations in hematologic conditions like paroxysmal nocturnal hemoglobinuria and can speak to this broader topic of somatic mutations as the cause of diseases beyond the field of oncology. The second speaker is Dr. Eli Diamond, an expert on histiocytosis who will discuss Erdheim-Chester disease as the prototype of a condition rheumatologists will see and must understand, from genetics to diagnosis to treatment.
